دورية أكاديمية

Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN

التفاصيل البيبلوغرافية
العنوان: Daratumumab in transplant-eligible patients with newly diagnosed multiple myeloma: final analysis of clinically relevant subgroups in GRIFFIN
المؤلفون: Chari, AjaiAff1, IDs41408024010886_cor1, Kaufman, Jonathan L., Laubach, Jacob, Sborov, Douglas W., Reeves, Brandi, Rodriguez, Cesar, Silbermann, Rebecca, Costa, Luciano J., Anderson, Jr, Larry D., Nathwani, Nitya, Shah, Nina, Bumma, Naresh, Holstein, Sarah A., Costello, Caitlin, Jakubowiak, Andrzej, Wildes, Tanya M., Orlowski, Robert Z., Shain, Kenneth H., Cowan, Andrew J., Pei, Huiling, Cortoos, Annelore, Patel, Sharmila, Lin, Thomas S., Voorhees, Peter M.Aff20, IDs41408024010886_cor24, Usmani, Saad Z.Aff21, IDs41408024010886_cor25, Richardson, Paul G.
المصدر: Blood Cancer Journal. 14(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:20445385
DOI:10.1038/s41408-024-01088-6